CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

This study is currently recruiting participants.
Verified August 2012 by Baylor College of Medicine
Sponsor:
Collaborators:
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
catherine bollard, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00840853
First received: February 9, 2009
Last updated: August 8, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2029
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)